A106S (p.Ala106Ser) variant of KRT4 (Keratin, type II cytoskeletal 4)

A106S (p.Ala106Ser) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.21 / 1. The record also includes population frequency data and structural context.

A106S (p.Ala106Ser) variant details